“Our goal is to treat more patients with mitral regurgitation”
Last month, Abbott announced US Food and Drug Administration (FDA) approval of a new trial—REPAIR MR—to evaluate the safety and efficacy of percutaneous edge-to-edge...
EXCEL may damage relations between interventional cardiologists and cardiac surgeons
The debate over the results of EXCEL shows no sign of abating, and there seems to be a division between cardiac surgeons and interventional...
Further innovation and research is required for thrombus aspiration in PCI
The TASTE and TOTAL studies suggested that routine thombus aspiration in patients undergoing percutaneous coronary intervention (PCI) did not provide mortality benefit and may...
BIBA Briefings: Sapien 3 becomes first TAVI valve to be approved for low-risk patients...
Edwards Lifesciences has received the CE mark for its Sapien 3 transcatheter aortic valve implantation (TAVI) device to be used to manage aortic stenosis...
